Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TITAN PHARMACEUTICALS INC | 65,000 | reported | 05 Jan 2022 | tx 28+3,208,400 |
| GALECTIN THERAPEUTICS INC | 60,000 | reported | 23 Jan 2025 | tx 34+757,866−233,579 |
| CURIS INC | 0 | reported | 20 Mar 2026 | tx 26+1,271,534−18,520 |
| MEDAREX INC | 0 | reported | 01 Sept 2009 | tx 10+75,882−75,882 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2026 | CONVERSION | CURIS INC | 26,667 | — | |
| 20 Mar 2026 | CONVERSION | CURIS INC | 20 | — | deriv |
| 17 Mar 2026 | GRANT_AWARD | CURIS INC | 26,667 | — | deriv |
| 17 Mar 2026 | GRANT_AWARD | CURIS INC | 26,667 | — | deriv |
| 17 Mar 2026 | GRANT_AWARD | CURIS INC | 20 | — | deriv |
| 17 Mar 2026 | GRANT_AWARD | CURIS INC | 26,667 | — | deriv |
| 20 May 2025 | GRANT_AWARD | CURIS INC | 14,400 | 3.13 USD | deriv |
| 28 Jan 2025 | GRANT_AWARD | CURIS INC | 1,600 | 3.13 USD | deriv |
| 23 Jan 2025 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | CURIS INC | 4,250 | 11.62 USD | deriv |
| 24 Jan 2024 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 50,000 | 0.00 USD | deriv |
| 26 Jan 2023 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 23 Jan 2023 | GRANT_AWARD | CURIS INC | 85,000 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | CURIS INC | 85,000 | 0.00 USD | deriv |
| 24 Jan 2022 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 05 Jan 2022 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 65,000 | 0.00 USD | deriv |
| 25 Mar 2021 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 70,000 | 0.00 USD | deriv |
| 25 Mar 2021 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 10 Feb 2021 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |
| 28 Jan 2021 | GRANT_AWARD | CURIS INC | 33,000 | 0.00 USD | deriv |
| 02 Mar 2020 | GRANT_AWARD | CURIS INC | 180,000 | 0.00 USD | deriv |
| 09 Jan 2020 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 30,000 | 0.00 USD | deriv |
| 02 Apr 2019 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 200,000 | 0.00 USD | deriv |
| 22 Feb 2019 | EXERCISE | GALECTIN THERAPEUTICS INC | 859 | 2.39 USD | |
| 21 Feb 2019 | SALE | GALECTIN THERAPEUTICS INC | 43,326 | 6.02 USD |
3 purchases reported after at least 12 months of silence — most recent on 16 Nov 2017.